• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种数据驱动的方法,用于利用在线和离线数据确定商业规模细胞培养过程中单克隆抗体生产率降低的原因。

A Data-Driven Approach for Leveraging Inline and Offline Data to Determine the Causes of Monoclonal Antibody Productivity Reduction in the Commercial-Scale Cell Culture Process.

作者信息

Zhang Sheng, Chen Hang, Wan Yuxiang, Wang Haibin, Qu Haibin

机构信息

Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

BioRay Pharmaceutical Co., Ltd., Taizhou 318000, China.

出版信息

Pharmaceutics. 2024 Aug 17;16(8):1082. doi: 10.3390/pharmaceutics16081082.

DOI:10.3390/pharmaceutics16081082
PMID:39204427
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11359819/
Abstract

The monoclonal antibody (mAb) manufacturing process comes with high profits and high costs, and thus mAb productivity is of vital importance. However, many factors can impact the cell culture process, and lead to mAb productivity reduction. Nowadays, the biopharma industry is actively employing manufacturing information systems, which enable the integration of both online data and offline data. Although the volume of data is large, related data mining studies for mAb productivity improvement are rare. Therefore, a data-driven approach is proposed in this study to leverage both the inline and offline data of the cell culture process to discover the causes of mAb productivity reduction. The approach consists of four steps, namely data preprocessing, phase division, feature extraction and fusion, and cluster comparing. First, data quality issues are solved during the data preprocessing step. Next, the inline data are divided into several phases based on the moving window -nearest neighbor method. Then, the inline data features are extracted via functional data analysis and combined with the offline data features. Finally, the causes of mAb productivity reduction are identified using the contrasting clusters via the principal component analysis method. A commercial-scale cell culture process case study is provided in this research to verify the effectiveness of the approach. Data from 35 batches were collected, and each batch contained nine inline variables and seven offline variables. The causes of mAb productivity reduction were identified to be the lack of nutrients, and recommended actions were taken according to the result, which was subsequently proven by six validation batches.

摘要

单克隆抗体(mAb)的生产过程利润高、成本也高,因此单克隆抗体的生产率至关重要。然而,许多因素会影响细胞培养过程,导致单克隆抗体生产率降低。如今,生物制药行业正积极采用制造信息系统,该系统能够整合在线数据和离线数据。尽管数据量很大,但针对提高单克隆抗体生产率的相关数据挖掘研究却很少。因此,本研究提出了一种数据驱动的方法,利用细胞培养过程中的在线和离线数据来发现单克隆抗体生产率降低的原因。该方法包括四个步骤,即数据预处理、阶段划分、特征提取与融合以及聚类比较。首先,在数据预处理步骤中解决数据质量问题。接下来,基于移动窗口最近邻方法将在线数据划分为几个阶段。然后,通过功能数据分析提取在线数据特征,并与离线数据特征相结合。最后,使用主成分分析方法通过对比聚类来确定单克隆抗体生产率降低的原因。本研究提供了一个商业规模细胞培养过程的案例研究,以验证该方法的有效性。收集了35个批次的数据,每个批次包含9个在线变量和7个离线变量。确定单克隆抗体生产率降低的原因是营养物质缺乏,并根据结果采取了建议措施,随后六个验证批次证明了该结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/5869cbd17eda/pharmaceutics-16-01082-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/572a68263716/pharmaceutics-16-01082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/fadb28bd13ae/pharmaceutics-16-01082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/1f4f5d8d3fc1/pharmaceutics-16-01082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/f4aed367080c/pharmaceutics-16-01082-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/1dfff27fda1a/pharmaceutics-16-01082-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/3e00d98f7671/pharmaceutics-16-01082-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/1b08be8a61b9/pharmaceutics-16-01082-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/e09c39deac71/pharmaceutics-16-01082-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/fd251eaf90d8/pharmaceutics-16-01082-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/cedd2edebe8b/pharmaceutics-16-01082-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/7ffc1d6f9e20/pharmaceutics-16-01082-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/c8a8025a8fd7/pharmaceutics-16-01082-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/5869cbd17eda/pharmaceutics-16-01082-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/572a68263716/pharmaceutics-16-01082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/fadb28bd13ae/pharmaceutics-16-01082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/1f4f5d8d3fc1/pharmaceutics-16-01082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/f4aed367080c/pharmaceutics-16-01082-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/1dfff27fda1a/pharmaceutics-16-01082-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/3e00d98f7671/pharmaceutics-16-01082-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/1b08be8a61b9/pharmaceutics-16-01082-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/e09c39deac71/pharmaceutics-16-01082-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/fd251eaf90d8/pharmaceutics-16-01082-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/cedd2edebe8b/pharmaceutics-16-01082-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/7ffc1d6f9e20/pharmaceutics-16-01082-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/c8a8025a8fd7/pharmaceutics-16-01082-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfd3/11359819/5869cbd17eda/pharmaceutics-16-01082-g013.jpg

相似文献

1
A Data-Driven Approach for Leveraging Inline and Offline Data to Determine the Causes of Monoclonal Antibody Productivity Reduction in the Commercial-Scale Cell Culture Process.一种数据驱动的方法,用于利用在线和离线数据确定商业规模细胞培养过程中单克隆抗体生产率降低的原因。
Pharmaceutics. 2024 Aug 17;16(8):1082. doi: 10.3390/pharmaceutics16081082.
2
Method Development and Validation of an Inline Process Analytical Technology Method for Blend Monitoring in the Tablet Feed Frame Using Raman Spectroscopy.采用拉曼光谱法在线过程分析技术在片剂供料框中进行混合监测的方法开发与验证。
Anal Chem. 2018 Jul 17;90(14):8436-8444. doi: 10.1021/acs.analchem.8b01009. Epub 2018 Jul 3.
3
Effective filter screening approach with fractionation for enabling inline filtration of protein A eluate.一种有效的分级过滤筛选方法,用于实现蛋白A洗脱液的在线过滤。
Biotechnol Appl Biochem. 2019 Mar;66(2):216-223. doi: 10.1002/bab.1713. Epub 2018 Nov 30.
4
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response.在线和离线体外光分离术:设备性能、细胞产量和临床反应。
J Clin Apher. 2021 Feb;36(1):118-126. doi: 10.1002/jca.21851. Epub 2020 Oct 15.
5
Transfer of continuous manufacturing process principles for mAb production in a GMP environment: A step in the transition from batch to continuous.在 GMP 环境下将单抗生产的连续制造工艺原理转移:从批处理到连续生产的转变的一步。
Biotechnol Prog. 2022 Jul;38(4):e3259. doi: 10.1002/btpr.3259. Epub 2022 Apr 26.
6
Stability of antibody productivity is improved when hybridoma cells are entrapped in calcium alginate beads.当杂交瘤细胞被包埋在海藻酸钙珠中时,抗体产生能力的稳定性会得到提高。
Biotechnol Bioeng. 1993 Nov 5;42(9):1131-5. doi: 10.1002/bit.260420917.
7
Transfer of a three step mAb chromatography process from batch to continuous: Optimizing productivity to minimize consumable requirements.将三步单克隆抗体色谱法从批次处理转换为连续处理:优化生产率以尽量减少耗材需求。
J Biotechnol. 2017 Jan 20;242:11-18. doi: 10.1016/j.jbiotec.2016.12.005. Epub 2016 Dec 6.
8
Does Offline Beat Inline Treatment: Investigation into Extracorporeal Photopheresis.离线治疗是否优于在线治疗:体外光化学疗法的研究
Transfus Med Hemother. 2020 Jun;47(3):198-204. doi: 10.1159/000506750. Epub 2020 Mar 27.
9
Changes in monoclonal antibody productivity of recombinant BHK cells immobilized in collagen gel particles.固定化在胶原凝胶颗粒中的重组 BHK 细胞中单克隆抗体产量的变化。
Cytotechnology. 1997 Jan;23(1-3):5-12. doi: 10.1023/A:1007959400666.
10
Modeling of cell culture damage and recovery leads to increased antibody and biomass productivity in CHO cell cultures.细胞培养损伤与恢复的建模可提高中国仓鼠卵巢细胞培养中抗体和生物量的产量。
Biotechnol J. 2014 Sep;9(9):1152-63. doi: 10.1002/biot.201300287. Epub 2014 Jul 11.

本文引用的文献

1
Development of an in-line Raman analytical method for commercial-scale CHO cell culture process monitoring: Influence of measurement channels and batch number on model performance.开发一种用于商业规模 CHO 细胞培养过程监测的在线 Raman 分析方法:测量通道和批次数量对模型性能的影响。
Biotechnol J. 2024 Jan;19(1):e2300395. doi: 10.1002/biot.202300395. Epub 2024 Jan 5.
2
Cell-culture process optimization via model-based predictions of metabolism and protein glycosylation.通过基于模型的代谢和蛋白质糖基化预测来优化细胞培养工艺。
Biotechnol Adv. 2023 Oct;67:108179. doi: 10.1016/j.biotechadv.2023.108179. Epub 2023 May 29.
3
Data-driven prediction models for forecasting multistep ahead profiles of mammalian cell culture toward bioprocess digital twins.
基于数据驱动的预测模型,用于预测哺乳动物细胞培养的多步提前曲线,以实现生物工艺数字孪生。
Biotechnol Bioeng. 2023 Sep;120(9):2494-2508. doi: 10.1002/bit.28405. Epub 2023 Apr 20.
4
Top companies and drugs by sales in 2022.2022年销售额排名靠前的公司和药品。
Nat Rev Drug Discov. 2023 Apr;22(4):260. doi: 10.1038/d41573-023-00039-3.
5
Biopharmaceutical benchmarks 2022.2022 年生物制药基准报告
Nat Biotechnol. 2022 Dec;40(12):1722-1760. doi: 10.1038/s41587-022-01582-x.
6
Comparison of mechanistic and hybrid modeling approaches for characterization of a CHO cultivation process: Requirements, pitfalls and solution paths.用于表征中国仓鼠卵巢细胞(CHO)培养过程的机理建模方法与混合建模方法的比较:要求、陷阱及解决途径。
Biotechnol J. 2023 Jan;18(1):e2200381. doi: 10.1002/biot.202200381. Epub 2022 Nov 29.
7
Optimization of a mAb production process with regard to robustness and product quality using quality by design principles.运用质量源于设计原则,优化单克隆抗体生产工艺,提升稳健性和产品质量。
Eng Life Sci. 2022 Jun 3;22(7):484-494. doi: 10.1002/elsc.202100172. eCollection 2022 Jul.
8
From cell line development to the formulated drug product: The art of manufacturing therapeutic monoclonal antibodies.从细胞系开发到制定药物产品:治疗性单克隆抗体的制造艺术。
Int J Pharm. 2021 Feb 1;594:120164. doi: 10.1016/j.ijpharm.2020.120164. Epub 2020 Dec 10.
9
Digital Twins for Bioprocess Control Strategy Development and Realisation.数字孪生在生物工艺控制策略开发和实现中的应用。
Adv Biochem Eng Biotechnol. 2021;177:63-94. doi: 10.1007/10_2020_151.
10
Towards smart biomanufacturing: a perspective on recent developments in industrial measurement and monitoring technologies for bio-based production processes.迈向智能生物制造:生物基生产过程中工业测量和监测技术的最新发展透视。
J Ind Microbiol Biotechnol. 2020 Nov;47(11):947-964. doi: 10.1007/s10295-020-02308-1. Epub 2020 Sep 7.